Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

PS Kishnani, PC Goldenberg, SL DeArmey… - Molecular genetics and …, 2010 - Elsevier
Deficiency of acid alpha glucosidase (GAA) causes Pompe disease, which is usually fatal if
onset occurs in infancy. Patients synthesize a non-functional form of GAA or are unable to …

[HTML][HTML] Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

PS Kishnani, PC Goldenberg, SL DeArmey… - Molecular genetics …, 2010 - ncbi.nlm.nih.gov
Deficiency of acid alpha glucosidase (GAA) causes Pompe disease, which is usually fatal if
onset occurs in infancy. Patients synthesize a non-functional form of GAA or are unable to …

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

PS Kishnani, PC Goldenberg, SL DeArmey… - Molecular Genetics and …, 2010 - infona.pl
Deficiency of acid alpha glucosidase (GAA) causes Pompe disease, which is usually fatal if
onset occurs in infancy. Patients synthesize a non-functional form of GAA or are unable to …

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

PS Kishnani, PC Goldenberg… - Molecular genetics …, 2010 - pubmed.ncbi.nlm.nih.gov
Deficiency of acid alpha glucosidase (GAA) causes Pompe disease, which is usually fatal if
onset occurs in infancy. Patients synthesize a non-functional form of GAA or are unable to …

[PDF][PDF] Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

PS Kishnani, PC Goldenberg, SL DeArmey, J Heller… - 2009 - amda-pompe.org
abstract Deficiency of acid alpha glucosidase (GAA) causes Pompe disease, which is
usually fatal if onset occurs in infancy. Patients synthesize a non-functional form of GAA or …

[PDF][PDF] Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

PS Kishnani, PC Goldenberg, SL DeArmey… - Molecular Genetics …, 2010 - academia.edu
abstract Deficiency of acid alpha glucosidase (GAA) causes Pompe disease, which is
usually fatal if onset occurs in infancy. Patients synthesize a non-functional form of GAA or …

[引用][C] Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

PS Koshnani, PC Goldenberg, SL DeArmey… - … METABOLISM 99 (1) …, 2010 - ir.sinica.edu.tw
Issue Date: 2010 Relation: MOLECULAR GENETICS AND METABOLISM 99 (1), 26-33 URI:
http://ir. sinica. edu. tw/handle/201000000A/22670 ISSN: http://gateway. isiknowledge …

Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants.

PS Kishnani, PC Goldenberg, SL DeArmey… - Molecular Genetics …, 2010 - europepmc.org
Deficiency of acid alpha glucosidase (GAA) causes Pompe disease, which is usually fatal if
onset occurs in infancy. Patients synthesize a non-functional form of GAA or are unable to …

[引用][C] Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants

PS Kishnani, PC Goldenberg, SL DeArmey… - Molecular Genetics and …, 2010 - cir.nii.ac.jp
Cross-reactive immunologic material status affects treatment outcomes in Pompe disease
infants | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …